Skip to main content

Animations

MJFF Publications

1421 - 1430 of 6433 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • 2024
  • 2023
  • 2023
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cts.13720
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00672-8
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Genotype–phenotype correlation in PRKN-associated Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00677-3
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-024-02706-0
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Profiling migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clusters
    Journal Name: Neurological Sciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10072-023-07118-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/trc2.12461
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Why Therapeutic Trials Fail in Primary Tauopathies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29322
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29358
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29725
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13729
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.